Difference-in-Differences for Health Policy and Practice: A Review of Modern Methods
Open accessAbstract
Difference-in-differences (DiD) is a popular observational causal inference method in health policy, employed to evaluate the real-world impact of policies and programs. To estimate treatment effects, DiD relies on a "parallel trends assumption" that treatment and comparison groups would have had parallel trajectories on average in the absence of an intervention. Recent years have seen both growing use of DiD in health policy and medicine and rapid advancements in DiD methods. To support DiD implementation in these fields, this paper reviews and synthesizes best practices and recent innovations. We provide recommendations to practitioners in four areas: (1) assessing causal assumptions; (2) adjusting for covariates and other approaches to relax causal assumptions; (3) accounting for staggered treatment timing; and (4) conducting robust inference, especially when normal-based clustered standard errors are inappropriate. For each, we explain challenges and common pitfalls in traditional DiD and recommend methods to address these. We explore current treatment of these topics through a focused literature review of medical DiD studies.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
86 of 153 cited sources checked · 54 supported · 2 flagged · accuracy not yet measured
- Findingcitation
Many reviewed papers showed an immediate and persistent jump in outcome levels after the intervention.
“Many papers [54, 64, 80-83] showed an immediate and persistent jump in outcome levels after the intervention.”
Quote in the paperNot a substantial claim3 of 6 sources checked- cites [54] source
- cites [64] source
The Results (page not provided) associate adoption of antibullying laws with reductions, not a jump upward, in the odds of suicide planning and attempts among LGBQ-identifying students. The paper reports that its event-study estimates were generally consistent with parallel pretreatment trends, but does not report an immediate and persistent increase after adoption. (LLM, conf=0.81)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [80] source
The Methods and Applying Time-Varying DiD For Pharmacy Closures sections describe measuring monthly anticonvulsant fills before and after pharmacy closure, but the passages in our copy do not report an immediate or persistent increase. Searches for post-closure increases and outcome trends found no passage establishing the claimed jump; the paper also does not assess whether many reviewed papers showed one. (LLM, conf=0.72)
Experimental — accuracy not yet measured - cites [81] source
- cites [82] source
- cites [83] source
- Findingown data
Medicare- or Medicaid-related interventions were the most common policy category among the reviewed DiD studies, with 10 studies (24%).
“with interventions related to Medicare or Medicaid as the most popular (n = 10, 24%) [49-58].”
Quote in the paperNot a substantial claim6 of 10 sources checked- cites [49] source
The Design, Setting, and Participants passage describes a difference-in-differences study comparing ambulatory care use across insurance groups, including Medicaid and Medicare. It does not identify a Medicare- or Medicaid-related policy intervention; the exposure studied is the pandemic. As one of citations [49–58], this paper also cannot establish the citing review’s aggregate count or ranking. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [50] source
- cites [51] source
- cites [52] source
- cites [53] source
- cites [54] source
- cites [55] source
- cites [56] source
- cites [57] source
- cites [58] source
- Premisecitation
DiD can estimate treatment effects even when no comparison group is exactly comparable to the treatment group.
“DiD allows for treatment effect estimation even when there exist no comparison groups that are exactly comparable to the treatment groups.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [1] source
- Findingcitation
Some reviewed studies found no immediate level change but increasing treatment effects over time or after a period of treatment adoption.
“Others [10, 65] found no immediate level changes but increasing treatment effects over time and/or after a period of treatment adoption, similar to columns (b) and (c) in Figure 2.”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [10] source
The Results section (page unavailable) reports that opioid overdose mortality increased in each of the first five years after plant closure, supporting an effect that grew over time. It does not establish that there was no immediate level change, and it does not describe a period of treatment adoption. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [65] source
- Interpretationcitation
In cross-sectional data where covariates affect the outcome level, adding time-varying covariates to TWFE rather than a saturated specification fits covariate coefficients partly based on time heterogeneity in treatment effects.
“In Case 1 (cross-sectional data, covariates affect outcome’s level), although this will reduce bias, adding time-varying covariates into TWFE, rather than a saturated specification, will fit covariate coefficients in part based on time heterogeneity in treatment effects [24, 94].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [94] source
In §2 (p. 8), Wolfers says that when a single treatment dummy fails to capture the dynamic response, state-specific trend controls partly reflect that response. In §2 (p. 9), he instead models the adjustment path explicitly. This supports the claimed mechanism, but the paper analyzes a state panel and state-specific trends, not the stated cross-sectional case or a general comparison of time-varying covariates in TWFE with a saturated specification; it also does not establish that adding them reduces bias. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- Premisecitation
Several authors have developed DiD estimators for staggered adoption, where treatment starts at different calendar times for different units.
“For example, several authors have developed estimators for cases when treatment started at different calendar times for different units (“staggered adoption”) [34, 35, 45-48].”
Quote in the paperNot a substantial claim5 of 6 sources checked - Interpretationcitation
Traditional pre-trend tests can mislead because they may lack enough statistical power to detect a parallel trends violation even when non-parallel pre-intervention trends exist.
“However, as several papers have noted [20, 24, 76-77], these tests can be misleading because they may not have adequate statistical power to detect a violation, even if there are non-parallel pre-intervention trend differences between treatment and comparison groups [20, 24, 76-77].”
Quote in the paperSubstantial claim2 of 4 sources checked - Premisecitation
Other work has adapted parallel trends to survival analysis with time-to-event data by formalizing a hazard-rate version of parallel trends.
“Other work has adapted the parallel trends assumption to a survival analysis with time-to-event data, formalizing a version of parallel trends on hazard rates [70, 71].”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [70] source
- cites [71] source
The Methods (Statistical Analysis; page unavailable) use a time-to-event Cox model for COVID-19 diagnosis hazards and state an identifying assumption that diagnosis risk would have followed the same trajectory in exposed and comparison states absent exposure. This supports an adaptation of parallel-trends reasoning to survival analysis, but our copy does not formalize a parallel-trends assumption specifically on hazard rates. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- The authors state this as an assumption: Treatment and comparison groups would have had parallel average outcome trajectories absent the intervention.
- Interpretationcitation
If parallel trends holds in the outcome's original levels, it generally will not hold after log transformation unless treatment was randomized or there were no differential time trends.
“For example, if the parallel trends assumption holds in the outcome variable’s original levels, it will generally not hold in log-transformed levels (for other transformations, see [67, 68]), unless there was randomization of treatment and/or no differential time trends [32].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [32] source
The Introduction says parallel trends can hold in levels but not logs, and that insensitivity to functional form requires restrictive conditions. But it identifies a third condition beyond random assignment or stable outcomes: a mixture of the two. Section 3, Example 3 shows parallel trends holding in both levels and logs under that hybrid condition, so the claim’s list of exceptions is incomplete. (LLM, conf=0.86)
Experimental — accuracy not yet measured
- The authors state this as an assumption: Treatment and comparison groups would have had parallel average outcome trajectories absent the intervention.
- Interpretationcitation
Saturated specifications allow researchers to estimate a set of treatment effects and aggregate them into one overall ATT using user-specified weights.
“With saturated specifications, researchers can estimate a set of treatment effects that can be aggregated into one overall ATT of interest through user-specified weights [34].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [34] source
- The authors state this as an assumption: Average untreated outcome changes are equal across adoption cohorts over time.
- Premisecitation
Many DiD studies add covariates directly into the TWFE specification to adjust for confounders.
“Mirroring methods used in other observational studies, many DiD studies add covariates directly into the TWFE specification (Equation 2) to adjust for confounders [17, 89].”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [17] source
Section 4.2 (“Parallel trends conditional on covariates”; page unavailable) discusses augmenting a TWFE specification with covariate controls to make conditional parallel trends more credible. It does not establish that many DiD studies do this, and the specification it discusses uses time-by-covariate interactions rather than simply adding covariates directly. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [89] source
- Interpretationcitation
The TWFE treatment effect estimate is a weighted average of possible 2x2 comparisons over all groups and treatment times, including using early treated units as comparison units after treatment.
“This occurs because the treatment effect estimate produced by TWFE is a weighted average of possible 2 × 2 comparisons over all groups and treatment times, including using early treated units as comparison units after treatment [36].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [36] source
- Interpretationcitation
These sensitivity approaches allow researchers to evaluate robustness of conclusions across reasonable assumptions even without data on potential confounders.
“These approaches allow researchers to evaluate and communicate the robustness of conclusions across reasonable assumptions even lacking data on potential confounders (see examples [104, 105]).”
Quote in the paperSubstantial claim2 of 2 sources checked - Interpretationcitation
When the treatment effect changes over time, TWFE can flip the sign of the treatment effect.
“When the treatment effect is changing over time, this can even flip the sign of the treatment effect [17, 34, 36].”
Quote in the paperSubstantial claim3 of 3 sources checked - Premisecitation
Most work on sensitivity analysis for causal assumption violations has focused on parallel trends.
“As above, most work in this area has focused on sensitivity analyses for parallel trends: for example, Rambachan and Roth [91] proposed an approach to bound how large violations of parallel trends must be to meaningfully shift effect estimates and developed methods to construct valid confidence intervals for the treatment effect under certain violations.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [91] source
- Premisecitation
Many saturated models have been developed to address staggered treatment adoption issues.
“Many saturated models have been developed to address issues related to staggered treatment adoption [34, 35, 45-48].”
Quote in the paperSubstantial claim5 of 6 sources checked- cites [34] source
The Introduction describes this paper’s framework for staggered adoption and identifies several alternative DiD estimators developed to avoid pitfalls of standard specifications. It supports the claim that multiple approaches have been developed, but the passages do not characterize them as saturated models; a search for “saturated” found no supporting passage. (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [35] source
- cites [45] source
Section 3 says methods for staggered treatment entry have grown rapidly, and Section 4.3 describes alternative techniques that address bias from staggered entry. The paper also describes a fully saturated FLEX specification, but these passages do not establish that many of the developed models are saturated. Page numbers are unavailable in our copy. (LLM, conf=0.79)
Experimental — accuracy not yet measured - cites [46] source
The Introduction says several papers have proposed estimators that address problems in staggered-adoption designs while allowing treatment effects to vary arbitrarily. It does not describe those approaches as saturated models, so that specific characterization is not established by our copy. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [47] source
- cites [48] source
In III.C, the paper uses stacked event-by-event estimates to check whether negative weighting from staggered treatments drives its results. In III (Robustness Checks), it also describes a highly saturated model, but that model adds controls for time-varying heterogeneity; the paper does not present it as a model developed to address staggered-adoption issues. Page numbers are unavailable in our copy. (LLM, conf=0.83)
Experimental — accuracy not yet measured
- Interpretationcitation
With staggered treatment timing, static TWFE can yield a biased ATT unless treatment effects are homogeneous over time and across all adoption cohorts.
“In this case, conducting DiD with a static TWFE specification (Equation 2) can lead to a biased ATT estimate unless treatment effects are homogeneous both over time and across all treatment adoption cohorts (Table 3, row 1) [17].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [17] source
- Premisecitation
Other group-time estimators differ in their choice of comparison groups and pre-intervention time periods.
“Other group-time estimators differ in the choice of comparison groups and pre-intervention time periods [17, 107-108].”
Quote in the paperNot a substantial claim2 of 3 sources checked - Interpretationcitation
Conformal inference can perform well when many time periods are available.
“Alternatively, conformal inference can perform well when there are many time periods available.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [42] source
- Findingown data
Most reviewed studies gave little context-specific support for their causal assumptions or for the treatment effect patterns they observed.
“Most studies provided little contextual support for causal assumptions or the observed patterns of treatment effects.”
Quote in the paperSubstantial claim - Findingcitation
PubMed search results for the term difference-in-differences rose from 2 in 2000 to 23 in 2010 and 841 in 2024.
“PubMed search results for “difference-in-differences” increasing from 2 in 2000 (0.4 per 100 000 PubMed entries) to 23 in 2010 (2.4/100 000) and 841 in 2024 (48/100 000) [15, 16].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [15]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [16]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
Two-thirds of the reviewed articles (28 studies, 67%) used traditional pre-trend tests with a null hypothesis of no parallel trends violation.
“Two-thirds of the articles we reviewed (n = 28, 67%) implemented traditional pre-trend tests, with a null of no violation of parallel trends.”
Quote in the paperNot a substantial claim - Findingown data
Nearly half of the reviewed studies (18 studies, 43%) reported an event study plot.
“Close to half (n = 18, 43%) of the studies reported an event study plot.”
Quote in the paperNot a substantial claim - Findingown data
Of the reviewed papers that adjusted for covariates, 27 (79%) directly added covariates into regression specifications.
“with 27 (79%) directly adding the covariates into regression specifications.”
Quote in the paperNot a substantial claim - Findingown data
None of the reviewed papers used a bounding method to explore the impact of parallel trends violations.
“None of the papers used a bounding method to explore the impact of parallel trends violations.”
Quote in the paperNot a substantial claim - Findingown data
20 of 42 reviewed studies (48%) had a staggered treatment design.
“In our literature review, 20 (48%) of the 42 studies had a staggered treatment design”
Quote in the paperNot a substantial claim - Findingown data
34 of 42 reviewed papers (81%) adjusted for covariates.
“Among papers we reviewed, most (34 of 42, 81%) adjusted for covariates in their analyses”
Quote in the paperNot a substantial claim - Findingown data
Among the reviewed papers that directly added covariates, nine studies (33%) used a saturated model.
“Among them, nine studies (33%) employed a saturated model.”
Quote in the paperNot a substantial claim - Findingown data
Five reviewed studies (15%) conducted matching or weighting based on covariates.
“Five studies (15%) conducted matching or weighting based on the covariates”
Quote in the paperNot a substantial claim - Findingown data
40 of 42 reviewed papers (95%) used normal-based standard errors.
“Among papers reviewed, normal-based standard errors were by far the most common method (n = 40, 95%) for conducting inference.”
Quote in the paperNot a substantial claim - Findingown data
About half of the staggered-treatment studies (9, 45%) used static TWFE as the main estimator.
“however, about half of them (n = 9, 45%) used a static TWFE model as the main estimator.”
Quote in the paperNot a substantial claim - Findingown data
Among those clustering at treatment assignment, 6 (30%) had large numbers of clusters or used methods accounting for small numbers of treatment and/or comparison clusters.
“Among them, 30% (n = 6) had either large numbers of clusters or used methods that account for a small number of treatment and/or comparison clusters.”
Quote in the paperNot a substantial claim - Findingown data
Of the remaining staggered-treatment studies using staggered estimators (10, 50% of all staggered studies), Callaway and Sant'Anna (3, 30%) and stacked DiD (3, 30%) were most popular.
“Of the remaining studies that implemented estimators accounting for the staggered treatment (n = 10, 50% of all studies with staggered treatment), Callaway and Sant’Anna (n = 3, 30%) and stacked DiD (n = 3, 30%) were the most popular methods.”
Quote in the paperNot a substantial claim - Findingown data
20 reviewed studies (48%) clustered standard errors at the level of treatment assignment.
“48% of studies (n = 20) clustered standard errors at the level of treatment assignment.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Under the parallel trends, no-anticipation, and SUTVA assumptions, the average treatment effect on the treated is identified.
“Therefore, the ATT is identified:”
Quote in the paperSubstantial claim- The authors state this as an assumption: Treatment and comparison groups would have had parallel average outcome trajectories absent the intervention.
- The authors state this as an assumption: The treatment has no effect on treated units before the intervention begins.
- The authors state this as an assumption: One unit's potential outcomes do not depend on other units' treatment status, implying no spillovers.
- Interpretationcitation
Adjusting for time-varying confounders risks adjusting for variables on the causal pathway if the confounder can be affected by treatment.
“First, this invites a risk of adjusting for variables on the causal pathway if the confounder can itself be affected by treatment.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [93]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Saturated techniques use versions of parallel trends that require parallel trends across specific time periods and units rather than on average across all periods and units.
“These techniques rely on different versions of the parallel trends assumption, requiring parallel trends across specific time periods and units, rather than over the average of time periods and units as in Assumption 1.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: Treatment and comparison groups would have had parallel average outcome trajectories absent the intervention.
- The authors state this as an assumption: Average untreated outcome changes are equal across adoption cohorts over time.
- Interpretationcitation
Running pre-trend tests and conditioning the analysis on passing them can increase bias in estimated treatment effects because the data that pass are a selected sample.
“However, conducting statistical pre-trend tests and conditioning the analysis on passing these tests may exacerbate bias in the estimated treatment effects because the observed draws of data that pass such tests are a select sample from the true underlying data-generating process [76].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [76] source
- Premisereasoning
DiD's causal assumptions cannot be directly tested because the counterfactual absent intervention is unobserved.
“DiD relies on assumptions—parallel trends, no anticipation, and SUTVA—that are not directly testable because we cannot observe what would have happened absent intervention.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Treatment and comparison groups would have had parallel average outcome trajectories absent the intervention.
- The authors state this as an assumption: The treatment has no effect on treated units before the intervention begins.
- The authors state this as an assumption: One unit's potential outcomes do not depend on other units' treatment status, implying no spillovers.
- Interpretationreasoning
Covariates that drive differential trends can confound treatment effect estimates.
“However, covariates that drive differential trends may confound treatment effect estimates.”
Quote in the paperSubstantial claim - Interpretationreasoning
Saturated group-time estimators allow flexible aggregation of treatment effects into an overall ATT specified by the user.
“Saturated group-time estimators provide researchers with the flexibility to aggregate treatment effects meaningfully into an overall ATT, as specified by the user, for example, larger weights in the first few post-treatment periods if the aim is to evaluate the short-term effect of an intervention.”
Quote in the paperSubstantial claim - Interpretationcitation
In stacked DiD, the overall ATT is implicitly a weighted average of cohort treatment effects, with weights reflecting the variance of each cohort-specific effect.
“The overall ATT is implicitly a weighted average of treatment effects in each cohort, with weights reflecing the variance of each cohort-specific treatment effect [47].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationnone given
Trajectory modeling produces consistent estimates when covariate-specific conditional expectation functions are correctly specified.
“Trajectory modeling produces consistent estimates if covariate-specific conditional expectation functions are correctly specified.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
- Premisecitation
Keele et al. developed a matching-based sensitivity analysis to assess how strong unobserved confounders must be to alter or reverse conclusions.
“Keele et al. [103] likewise developed a sensitivity analysis method based on matching to assess how strong unobserved confounders must be to alter or reverse their conclusions.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [103]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
Other methods allow treatment effect heterogeneity both across cohorts and over time.
“Nevertheless, there are other methods that allow for treatment effect heterogeneity both across cohorts and over time.”
Quote in the paperSubstantial claim - Interpretationnone given
Under different assumptions, these techniques may allow treatment effect estimation assuming conditional parallel trends.
“Under different assumptions, these techniques may allow for treatment effect estimation assuming conditional parallel trends.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
- Interpretationcitation
Doubly robust estimators produce consistent estimates when either the trajectory model or the propensity score model is correctly specified.
“Doubly robust (DR) estimators combine trajectory modeling and propensity score estimation and produce consistent estimates if either the trajectory model or the propensity score model is correctly specified: [29]”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [29] source
- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
- Interpretationreasoning
Dynamic TWFE partially addresses the problems of static TWFE in staggered settings.
“One simple extension to the static TWFE specification (Equation 2) is the dynamic TWFE specification, which partially addresses these problems.”
Quote in the paperNot a substantial claim - Interpretationreasoning
When treatment effects differ across adoption cohorts, the TWFE estimand may no longer reflect the ATT of interest.
“When treatment effects differ across adoption cohorts, this treatment effect estimand may no longer reflect the ATT of interest.”
Quote in the paperSubstantial claim - Premisecitation
Ye et al. proposed bounding bias by choosing two comparison groups with offsetting biases, assuming the treated group's counterfactual path is bracketed between them; DiD estimates from these groups provide lower and upper bounds on the treatment effect.
“Ye et al. [92] proposed bounding bias by choosing two comparison groups with offsetting biases, assuming that the treated group’s counterfactual path would have been sandwiched or “bracketed” between those of the chosen comparison groups. DiD estimates based on these two groups then provide lower and upper bounds on the treatment effect.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [92]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
IPW provides a consistent estimator for the ATT when the propensity score model is correctly specified.
“This approach provides a consistent estimator for the ATT if the propensity score model is correctly specified.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] source
- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
- Premisenone given
Several alternative methods have been proposed for inference with a small number of clusters.
“Several alternative methods have been proposed to conduct inference with a small number of clusters.”
Quote in the paperSubstantial claim - Interpretationnone given
DiD can allow rigorous causal interpretations in certain observational studies.
“It can allow for rigorous causal interpretations in certain observational studies.”
Quote in the paperSubstantial claim
- May combine two claims. 37
- Classified as probably not a substantial claim. 46
May combine two claims.
InterpretationcitationConformal inference assumes that the proportion of treated units in each cluster varies little over time and imposes strong parallel trends over all pre- and post-treatment periods.
“However, it assumes that the proportion of treated units in each cluster to vary little over time and imposes a strong parallel trends assumption over all pre- and post-treatment periods [42].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [42] source
The Introduction (p. 2) describes the method in terms of stationary, weakly dependent errors whose distribution is invariant under intervention. The Related Literature discussion (p. 5) says it does not model treatment assignment and requires a suitable model for the treated unit’s potential outcome. These stated requirements run counter to the attributed requirements about treated-unit proportions within clusters and strong parallel trends. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- The authors state this as an assumption: Conformal inference assumes that the proportion of treated units in each cluster varies little over time and imposes strong parallel trends over all pre- and post-treatment periods.
May combine two claims.
InterpretationcitationThe wider use of DiD has coincided with major methodological advances over the past decade that improved the method while making it harder to implement and interpret.
“Broader DiD adoption has been accompanied by significant methodological advancements over the past decade, which have refined the approach but rendered its implementation and interpretation more challenging [17-21].”
Quote in the paperSubstantial claim2 of 5 sources checked- cites [17] source
The Introduction describes DiD as popular and says a rapid wave of methodological papers has made it challenging for practitioners to keep up and even for experts to understand how the developments fit together. It does not say the advances made DiD results harder to interpret or the methods harder to implement; the Introduction says new methods can improve interpretability, and Section 3.5 says software packages make implementation straightforward. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [18] source
- cites [19] source
- cites [20] source
Section 4, “Testing for Preexisting Trends” (page unavailable), says DiD has grown in popularity and that researchers are now effectively required to test for pre-trends when data permit. The paper supports broader adoption and more demanding implementation, but it does not attribute those demands to major methodological advances over the past decade or say that such advances refined DiD while making interpretation harder. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [21]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationMany US health care policies were introduced at state or local levels, which left comparable states or localities untreated and enabled DiD designs.
“Broadly, these DiDs leveraged the fact that many US health care policies—such as phased insurance expansion [58], elimination of asset tests [65], and antibullying policies [64]—were introduced at the state- or local-level, leaving comparable states or localities untreated.”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [58] source
The citation is attached to “antibullying policies,” but no passage in our copy addresses such policies. The Methods (Statistical Analysis) instead describe a difference-in-differences study of Massachusetts Medicaid ACO implementation, comparing Medicaid-insured with privately insured children—not untreated states or localities. (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [65] source
- cites [64] source
Classified as probably not a substantial claim.
PremisecitationDifference-in-differences is a widely used observational causal inference method in health policy for evaluating the real-world effects of policies and programs.
“Difference-in-differences (DiD) is a popular observational causal inference method in health policy, employed to evaluate the real-world impact of policies and programs.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [1] source
The Conclusions describe difference-in-differences as a method for estimating the causal impact of population-level changes and discuss evaluating policies to improve population health. But the Introduction says it is used relatively infrequently by epidemiologists, and the Conclusions locate its widespread use in economics; the paper does not support calling it popular in health policy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
InterpretationcitationWhen formal theory is well developed, researchers can translate parallel trends into domain-specific conditions and use context to choose the outcome's functional form or scale, to which parallel trends is usually sensitive.
“Where formal theory is well-developed, researchers may be able to translate the parallel trends assumption into domain-specific conditions and use context to help select functional form or scale of the outcome, to which the parallel trends assumption is usually sensitive [17, 32, 66].”
Quote in the paperSubstantial claim3 of 3 sources checked- cites [17] source
Section 4.1 (page unavailable) says parallel trends is generally sensitive to whether outcomes are measured in levels or logs, and the paper advises researchers to justify their choice of functional form. Section 4.6 recommends using context-specific knowledge to assess parallel trends. The passages do not say that well-developed formal theory lets researchers translate parallel trends into domain-specific conditions or use context to select the outcome scale. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [32] source
- cites [66] source
The Methods section (Review tool for data collection; page unavailable) says the functional form of counterfactual infectious-disease trends should be justified and appropriate to the outcome. The Results section (Strength of methods assessment; page unavailable) identifies inappropriate outcome scales and missing justifications as common problems. These passages support using domain context to choose a form or scale, but do not address translating parallel trends into domain-specific conditions when formal theory is developed or say that parallel trends is usually sensitive to outcome scale. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- The authors state this as an assumption: Treatment and comparison groups would have had parallel average outcome trajectories absent the intervention.
May combine two claims.
PremisecitationRecent work has described epidemiological conditions needed for parallel trends with infectious disease outcomes under different transformations and specifications and has proposed estimators for that setting.
“Recent work has described epidemiological conditions required for parallel trends to hold with infectious disease outcomes under different outcome transformations and specifications, and proposed estimators for this purpose [27, 69].”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [27]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [69] source
In ‘Using difference-in-differences to evaluate policy effects on Covid-19 cases’ (page unavailable), Theorem 1 examines parallel trends under a stochastic SIRD model and finds that the assumption generally fails. The Introduction proposes an alternative estimator for policy effects. The state-level Results compare outcome transformations and specifications, but do not set out conditions under which parallel trends holds for each; they say none of the four TWFE specifications is compatible with the SIRD model. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- The authors state this as an assumption: Treatment and comparison groups would have had parallel average outcome trajectories absent the intervention.
Classified as probably not a substantial claim.
InterpretationcitationConditional parallel trends implies that parallel trends holds within covariate-defined strata, such as within smokers and within non-smokers.
“This implies parallel trends within populations in covariate-defined strata (e.g., parallel trends within smokers and non-smokers): [17, 34]”
Quote in the paperSubstantial claim2 of 2 sources checked- The authors state this as an assumption: Parallel trends holds within covariate-defined strata.
May combine two claims.
InterpretationcitationIn DiD, covariates that create only time-invariant level differences between treatment and comparison outcomes are not confounders, and omitting them does not bias ATT estimates.
“By contrast, in DiD, covariates that only produce time-invariant level differences between treatment and comparison outcomes are not confounders [89], and excluding them does not bias ATT estimates (Table 2, row 1).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [89] source
Classified as probably not a substantial claim. May combine two claims.
PremisecitationNon-inferiority tests set a null hypothesis that the parallel trends violation exceeds a threshold and allow DiD only when there is enough evidence to reject that null.
“One alternative is to consider non-inferiority tests [24, 78], which specify a null hypothesis that the violation of parallel trends exceeds some threshold (instead of no violation) and proceed with DiD only if there is sufficient evidence to reject the null [17, 24].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [78] source
- cites [17] source
Section 4.4.1 describes non-inferiority tests as setting a null of a large pre-treatment trend and rejecting it only with strong evidence that the trend is small. It does not prescribe proceeding with DiD only after rejection; the same section says these approaches provide no clear guidance when the test fails to reject. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationOne reviewed study found that the safer supply policy had an increasing treatment effect on opioid prescriptions over time.
“For instance, one study found an increasing treatment effect of the safer supply policy in opioid prescription over time [84].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [84] source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationCross-jurisdiction shopping can create spillover violations in soft drink tax evaluations, making neighboring jurisdictions unsuitable as comparison units.
“For example, if individuals can easily avoid a soft drink tax by shopping in a neighboring jurisdiction, researchers might want to remove these jurisdictions from the set of comparison groups [72].”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [72] source
- The authors state this as an assumption: One unit's potential outcomes do not depend on other units' treatment status, implying no spillovers.
May combine two claims.
PremisecitationMany newer DiD specifications are saturated, estimating an ATT for each post-intervention time period and sometimes for specific units or groups.
“Many new specifications are “saturated,” estimating an ATT specific to each post-intervention time period and sometimes to specific units or groups of units.”
Quote in the paperNot a substantial claim4 of 6 sources checked- cites [34] source
- cites [35] source
- cites [45] source
- cites [46] source
- cites [47]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [48] source
Section II.B estimates effects by event time, and Section III.C estimates effects separately for each minimum-wage event. The robustness checks in Section III call one model “highly saturated.” These passages support the paper as an example of time- and event-specific estimation, but they do not establish the broader claim that many new DiD specifications are saturated or describe those estimates as ATTs. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Classified as probably not a substantial claim.
InterpretationcitationWhen a policy is announced or enacted long before implementation, individuals may anticipate its adoption, so the pre-intervention period may need to end before that anticipation.
“Similarly, if a policy is announced or enacted in legislation for an extended period prior to implementation, researchers may end the pre-intervention period prior to the time at which individuals likely anticipated its adoption [73-75].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [73]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [74] source
- cites [75] source
- The authors state this as an assumption: The treatment has no effect on treated units before the intervention begins.
Classified as probably not a substantial claim.
PremisecitationThere is growing consensus that researchers should default to saturated group-time models, including estimators by Callaway and Sant'Anna, Sun and Abraham, and Borusyak, Jaravel, and Spiess.
“There is growing consensus that researchers should default to these saturated models, including estimators proposed by Callaway and Sant’Anna, Sun and Abraham, and Borusyak, Jaravel, and Spiess (Table 3, row 3) [34, 35, 46, 106].”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [34] source
The Introduction and Section 4 describe the paper’s group-time treatment-effect estimators, and the Introduction discusses related estimators by Sun and Abraham. Section 3 explains problems with conventional two-way fixed-effects estimates. The paper does not establish a growing consensus that researchers should default to saturated models or recommend the full set of named estimators as a default. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [35] source
- cites [46] source
The Introduction describes the Callaway–Sant’Anna and Sun–Abraham estimators as robust to arbitrary treatment-effect heterogeneity and proposes the authors’ own robust imputation estimator. It does not claim a growing consensus that researchers should default to saturated group-time models. The reference to a “default” in §4.3 concerns grouping for standard-error estimation in the authors’ Stata command, not a default choice of model. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [106] source
Section 2 (p. 4) identifies the Callaway–Sant’Anna, Sun–Abraham, and Borusyak et al. estimators in its discussion of flexible difference-in-differences methods. Section 5.4 (p. 14) compares some of these methods with TWFE. The passages do not say there is a growing consensus that researchers should default to saturated group-time models. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCallaway and Sant'Anna described approaches to aggregate individual group-time average treatment effects into an overall ATT estimate.
“They then described several approaches to aggregate individual group-time average treatment effects into an overall ATT estimate [34, 106].”
Quote in the paperNot a substantial claim2 of 2 sources checkedMay combine two claims.
PremisecitationIn a large empirical reanalysis, staggered-timing estimators sometimes produced substantially smaller treatment effect estimates and often larger standard errors, requiring more power to reject the null than TWFE.
“In a large empirical reanalysis [21], estimators that account for staggered treatment timing were found to sometimes produce substantially smaller treatment effect estimates. These estimators also often produced larger standard errors and would require more power to reject the null hypothesis than TWFE [21].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [21] source
May combine two claims.
InterpretationcitationStacked regression allows both time and cohort heterogeneity and requires parallel trends only over the horizon the researcher specifies.
“This approach allows both time and cohort heterogeneity, requiring parallel trends over only the horizon of time that the researcher specifies.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [48] source
May combine two claims.
InterpretationcitationThese alternatives provide well-defined causal parameters with transparent weights over 2x2 comparisons and avoid using treated units as comparison groups.
“Overall, these alternatives provide well-defined causal parameters with transparent weights over the 2 × 2 comparisons and avoid using treated units as comparison groups [17].”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [17] source
May combine two claims.
InterpretationcitationDynamic TWFE yields a sensible ATT estimand if heterogeneity exists only in time since treatment, but it requires the sequence of treatment effects to be the same across all cohorts regardless of calendar adoption time.
“The dynamic TWFE specification yields a sensible estimand for the ATT if heterogeneity only exists in the number of time periods since treatment, but it still requires the sequence of treatment effects to be the same across all cohorts regardless of calendar adoption time (Table 3, row 2) [35, 46].”
- Also stated in: § Recommendation 3: When Treatment Adoption Is Staggered, Use Saturated Estimators With Clean Comparison Groups, Particularly Those That Estimate Group-Time Effects · plain
“For example, dynamic TWFE allows treatment effects to be different in year 2 compared to year 3 following treatment adoption, but the year 2 effect is assumed to be the same across all adoption cohorts [17].”
Quote in the paperSubstantial claim2 of 3 sources checked- Also stated in: § Recommendation 3: When Treatment Adoption Is Staggered, Use Saturated Estimators With Clean Comparison Groups, Particularly Those That Estimate Group-Time Effects · plain
May combine two claims.
PremisecitationRambachan and Roth proposed a method to bound how large parallel trends violations must be to shift effect estimates and to construct valid confidence intervals under certain violations.
“Rambachan and Roth [91] proposed an approach to bound how large violations of parallel trends must be to meaningfully shift effect estimates and developed methods to construct valid confidence intervals for the treatment effect under certain violations.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [91] source
May combine two claims.
PremisecitationOther confounding-adjustment innovations include Bayesian trajectory modeling, machine learning for IPW and doubly robust estimators, and IPW using latent variables or marginal structural models.
“Other innovations in confounding adjustment methods include Bayesian approaches for trajectory modeling [96, 97], machine learning to estimate weights for IPW and doubly robust estimators [98-100], and IPW approaches driven by latent variables or marginal structure models to facilitate a better understanding of selection into treatment [100-102].”
Quote in the paperNot a substantial claim4 of 7 sources checked- cites [96] source
- cites [97] source
The cited paper falls within the citation groups for machine-learning-based IPW and doubly robust estimators, and for IPW using latent variables or marginal structural models. Its Materials and Methods instead describes Bayesian estimation of a negative binomial model; searches for inverse-probability weighting, machine learning, doubly robust estimation, latent variables, and marginal structural models found no passage addressing those methods. The Bayesian trajectory-modeling clause is attributed to different citations. (LLM, conf=0.74)
Experimental — accuracy not yet measured - cites [98] source
- cites [99] source
The sections on predicting treatment weights and doubly robust methods (pages not available in our copy) describe machine-learning-generated IPW weights, their use in marginal structural models, and machine learning with doubly robust estimators. The paper does not support the cited clause’s reference to latent-variable-driven IPW or its stated purpose of clarifying selection into treatment. The Bayesian trajectory-modeling clause cites other sources, not this one. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [100] source
- cites [101] source
- cites [102] source
The Introduction and Section 2 describe data-adaptive ensemble learning to estimate inverse-probability weights for marginal structural models, supporting those parts of the claim. The paper does not describe its approach as a doubly robust estimator or as latent-variable-driven IPW. The Bayesian trajectory-modeling clause is cited to other sources, not this paper. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationThe Callaway and Sant'Anna estimator uses only the last pre-treatment period for reference, invoking a weaker parallel trends assumption but possibly having lower power than estimators using all pre-intervention periods.
“The Callaway and Sant’Anna [34] estimator uses only the last pre-treatment period for reference, which invokes a weaker version of the parallel trends assumption”
- Also stated in: § Recommendation 3: When Treatment Adoption Is Staggered, Use Saturated Estimators With Clean Comparison Groups, Particularly Those That Estimate Group-Time Effects · hedged
“but may have correspondingly lower power [108] than estimators that use all pre-intervention periods as reference (e.g., [46]).”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [34] source
- cites [108]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [46] source
The Introduction (page unavailable) says the authors’ estimator uses all pre-treatment periods while alternatives use more limited information, and reports efficiency gains over versions equivalent to the Callaway and Sant’Anna estimator without extra controls. Section 2 (page unavailable) discusses weaker parallel-trends assumptions and says the Callaway and Sant’Anna assumptions are equivalent to the authors’ assumptions in a one-pre-period case. Our copy does not establish the specific claim that the Callaway and Sant’Anna estimator uses only the last pre-treatment period as its reference. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
- Also stated in: § Recommendation 3: When Treatment Adoption Is Staggered, Use Saturated Estimators With Clean Comparison Groups, Particularly Those That Estimate Group-Time Effects · hedged
Classified as probably not a substantial claim.
PremisecitationTechniques for conditional parallel trends fall into trajectory modeling and propensity score weighting.
“These fall into two main categories, which we denote trajectory modeling [28, 29, 86, 88, 95] and propensity score weighting [17, 30].”
Quote in the paperSubstantial claim1 of 7 sources checked- cites [28] source
- cites [29] source
- cites [86] source
- cites [88] source
- cites [95] source
- cites [17] source
- cites [30] source
- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
May combine two claims.
InterpretationcitationWith few clusters, normal-based clustered standard errors are typically anti-conservative, leading to inappropriately small p values and an inflated Type I error rate.
“If there are only a few clusters in the data, normal-based clustered standard errors are typically anti-conservative [114, 115], leading to inappropriately small p values and an inflated Type I error rate.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [114] source
- cites [115] source
The Introduction (page unavailable) reports that, with few treated units, standard-normal tests using heteroskedasticity-robust variance estimates can over-reject: in one simulation, the rejection rate was 15% at a nominal 5% level. It also says unit-clustered standard errors can massively underestimate uncertainty when there is one treated cluster. This supports the concern about small p values and inflated Type I error, but the cited analysis concerns few treated clusters, not few clusters in general, and does not establish that the problem is typical across all such settings. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationConley and Taber proposed estimating the distribution of errors in treated clusters using untreated clusters; this may be powerful with few treated but many untreated clusters.
“Conley and Taber proposed an approach to estimate the distribution of errors in the treated clusters using that from the untreated clusters [40]. This approach may be powerful when there are only a few treated clusters but many untreated ones from which to estimate the error distribution.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [40] source
May combine two claims.
InterpretationcitationNormal-based inference requires a substantial number of both treated and untreated clusters, such as at least 25 or 30 in each class, which may not exist in many DiD applications.
“While normal-based inference accounts for error correlation within clusters, it requires a substantial number of both treated and untreated clusters (e.g., at least 25 or 30 clusters in each class), which may not exist in many DiD applications (Table 4, row 1) [17, 114].”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [17] source
Section 5.1 says standard DiD inference relies on many treated and untreated clusters for an asymptotic normal approximation, and that many applications have too few, especially treated clusters. It does not specify a threshold of 25 or 30 clusters in each class. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [114] source
May combine two claims.
Findingown dataTwo reviewed papers implemented bootstrap algorithms for inference, one traditional and one wild cluster.
“Two papers implemented bootstrap algorithms for inference, one with traditional bootstrap [118] and another one with wild cluster bootstrap [119].”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
Findingown dataRemaining adjustment methods included dynamic TWFE (2), two-stage DiD by Gardner (1), and the d'Chaisemartin and D'Haultfoeuille estimator (1).
“The remaining adjustment methods included dynamic TWFE (n = 2), two-stage DiD proposed by Gardner [47] (n = 1), and the d’Chaisemartin and D’Haultfoeuille estimator [33] (n = 1).”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [47]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [33] source
Classified as probably not a substantial claim.
InterpretationcitationIt is recommended to estimate standard errors clustered at the level of treatment assignment.
“In all scenarios, it is recommended to estimate the standard errors clustered at the level of treatment assignment [17, 110-111].”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [17] source
Section 5.2 recommends clustering standard errors at the level where treatment is independently assigned, but calls this a rule of thumb from a design-based perspective. The citing sentence’s “in all scenarios” overstates that qualified recommendation; Section 5.1 also discusses alternative inference procedures for settings with few clusters. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [110]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [111] source
May combine two claims.
Findingown dataThe review surveyed DiD analyses published in three JAMA network journals from January 2022 through November 2024: JAMA had 13, JAMA Internal Medicine had 16, and JAMA Pediatrics had 13.
“we surveyed DiD analyses published in three Journal of American Medical Association (JAMA) network journals between January 2022 and November 2024: JAMA (n = 13, 31%), JAMA Internal Medicine (n = 16, 38%), and JAMA Pediatrics (n = 13, 31%)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNone of the reviewed articles discussed non-inferiority tests or calculated test power from pre-intervention data.
“None discussed non-inferiority tests or calculated test power based on pre-intervention data.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTwo reviewed studies used a doubly robust estimator.
“and two used a doubly robust estimator.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOf the 34 reviewed studies that adjusted for covariates, 28 (82%) included only baseline covariates, while six (18%) adjusted for both baseline and time-varying covariates.
“Twenty-eight out of these 34 studies that adjusted for covariates (82%) included only baseline covariates in their model specifications, while the other six (18%) adjusted for both baseline and time-varying covariates.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataOne reviewed study did not clearly specify its estimator.
“One study did not clearly specify its estimator.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFive reviewed papers (12%) studied an intervention assigned at the individual patient or physician level.
“Five papers (12%) studied an intervention that was assigned at an individual patient or physician level.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationnone givenDiD and two-way fixed effects are not interchangeable terms, because the TWFE estimator applies only to some DiD analyses.
“Importantly, the terms “DiD” and “TWFE” are not interchangeable; the TWFE estimator is only used in a subset of DiD analyses.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationSaturated models avoid several problems that arise with staggered treatment timing and time-varying covariates and permit more deliberate aggregation of treatment effects across groups.
“Saturated models, which will be discussed further throughout the text, both prevent several problems that can arise when incorporating staggered treatment timing and time-varying covariates and allow researchers to more intentionally aggregate ATTs across different groups.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Interpretationnone givenPre-intervention event study effects can be read as placebo effects that should be small with narrow confidence intervals and should not show trends or anticipation.
“The pre-intervention effects can be interpreted as placebo effects that should be small in magnitude with narrow confidence intervals, without evidence of trends or anticipation effects.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningWhen confounders vary over time, other study designs may be more appropriate than DiD.
“As a result, in this case, other study designs may be more appropriate than DiD.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
InterpretationreasoningWith cross-sectional data, adjusting for covariates that shift the outcome level may be needed because changing sample composition can drive differential trends.
“First, suppose researchers have cross-sectional data, meaning that different individuals are sampled at each observed time point. In this case, researchers may need to account for covariates that shift an outcome’s level, even if they do not affect an individual’s trajectory (Table 2, row 2, Case 1) because changing composition may drive differential trends.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenPost-intervention changes in the comparison group may indicate spillover effects.
“They should also consider whether changes in the comparison group post-intervention may suggest spillover effects.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: One unit's potential outcomes do not depend on other units' treatment status, implying no spillovers.
Classified as probably not a substantial claim.
InterpretationcitationEvent study estimates should not be judged by whether their confidence intervals overlap zero.
“As with tests of slope differences, event study estimates should not be evaluated based on whether confidence intervals overlap zero [24, 76].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [24]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [76] source
Classified as probably not a substantial claim.
InterpretationreasoningAdding covariates directly into a TWFE specification may not be appropriate.
“However, this approach may not be appropriate.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningWith cross-sectional or longitudinal/panel data, adjusting for covariates that shift the outcome trend may be needed.
“Second, in either cross-sectional or longitudinal/panel data (in which the same individuals are sampled at each time point), researchers may adjust for covariates that shift the outcome trend (Table 2, row 3, Case 2).”
Quote in the paperSubstantial claim- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
Classified as probably not a substantial claim.
InterpretationcitationNo anticipation and SUTVA together allow potential outcomes to be linked to observed outcomes, a condition sometimes called consistency.
“Together, no anticipation and SUTVA allow us to link the potential outcomes to the observed outcomes as follows, which is also sometimes referred to as consistency [44]:”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] source
- The authors state this as an assumption: The treatment has no effect on treated units before the intervention begins.
- The authors state this as an assumption: One unit's potential outcomes do not depend on other units' treatment status, implying no spillovers.
May combine two claims.
InterpretationcitationWith staggered treatment adoption, event study interpretation depends on the specification, and pre-intervention points may not show secular trends unless all are constructed relative to the same pre-intervention period.
“Further, when treatment adoption is staggered, the interpretation of event study plots depends on the specification [79], and pre-intervention points may not display secular trends unless they are all constructed relative to the same pre-intervention period (i.e., base period = “universal” in R or long2 in Stata).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [79]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing).
InterpretationreasoningDomain knowledge can help identify possible violations of the no-spillover and no-anticipation assumptions.
“Last, domain knowledge may help to inform potential violations of spillover and no-anticipation assumptions.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The treatment has no effect on treated units before the intervention begins.
- The authors state this as an assumption: One unit's potential outcomes do not depend on other units' treatment status, implying no spillovers.
Classified as probably not a substantial claim.
Premisenone givenFor treated units, the untreated potential outcome is not observed.
“Note that the untreated potential outcome is unobserved for treated units.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationcitationConditioning parallel trends on a time-varying variable makes it hard to define underlying parallel trends, because trends may not be parallel in any well-defined subgroup.
“Second, conditioning the parallel trends assumption on a time-varying variable makes it difficult to conceptualize a cohesive notion of underlying parallel trends—if trends are only parallel conditional on a time-varying variable, they may not be, in fact, believed to be parallel in any well-defined subgroup.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
Classified as probably not a substantial claim.
Premisenone givenHistorically, medical researchers mainly used adjustment for observed confounders and epidemiological designs to address selection bias in non-randomized treatment effect estimation.
“Historically, medical researchers relied primarily on adjustment for observed confounders (e.g., regression adjustment, stratification, propensity score weighting, or matching) and epidemiological designs (e.g., case control studies) to address selection bias when estimating treatment effects in non-randomized settings.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningEvent study plots are a useful diagnostic for assessing pre-intervention trends.
“Event study plots (e.g., Figure 2) provide another useful diagnostic for evaluating pre-intervention trends.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationEconometric causal inference methods such as DiD can adjust for some unobserved confounders and, in some cases, support rigorous causal interpretation of observational results.
“econometric causal inference methods, including difference-in-differences, that can adjust for some unobserved confounders and, in certain cases, allow for rigorous causal interpretations of results from observational studies.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [13]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [14] source
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenThe conditions under which the traditional DiD estimator is valid are well established in the literature.
“The conditions under which the DiD estimator derived above is valid are well-established in the literature.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
Interpretationnone givenThese models can invoke different versions of the parallel trends assumption, and researchers often need to specify the time periods and units over which parallel trends is believed to hold.
“These models can invoke different versions of the parallel trends assumption, and researchers often need to specify the time periods and units over which the parallel trends assumption is believed to hold.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChen et al. proposed methods to bound violation impact under different assumptions about the magnitude of anticipation effects.
“researchers may consider methods proposed by Chen et al. [73] to bound violation impact under different assumptions about the magnitude of anticipation effects.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [73]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- The authors state this as an assumption: No anticipation: treatment has no effect before implementation.
May combine two claims.
InterpretationreasoningIn case 2, bias may persist after adding covariates to TWFE because of the time-heterogeneity issue and because naive covariate addition typically does not allow trends to differ by covariate value.
“In Case 2 (cross-sectional or longitudinal data, covariates affect outcome’s trajectory), bias may persist after adding covariates to a TWFE specification both because of the above issue and because naïvely adding covariates typically does not allow trends to differ by covariate value (Table 2, row 3).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationSoftware for group-time estimators often allows user customization; the Sun and Abraham estimator can be implemented in R fixest with choices of reference periods and comparison group.
“In practice, software to implement these estimators also often allows for user customization. For example, the Sun and Abraham [35] estimator, motivated by strong parallel trends (Assumption 4), can be implemented with software (R fixest) that allows users to pick one or multiple reference periods and either never-treated or last-treated units as the comparison group [109].”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [35] source
- cites [109]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- The authors state this as an assumption: Strong parallel trends (Assumption 4) holds.
Classified as probably not a substantial claim. May combine two claims.
InterpretationreasoningWhen parallel trends are violated, researchers might consider potential confounders and use trajectory modeling, propensity score weighting, or doubly robust estimators to account for them.
“In summary, when faced with violations of parallel trends, researchers might carefully consider potential confounders and use trajectory modeling, propensity score weighting, or combined doubly robust estimators to account for them (Table 2, rows 2 and 3).”
Quote in the paperSubstantial claim- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
May combine two claims.
InterpretationreasoningThe dynamic TWFE assumption may not be plausible if early adopters had a different policy experience or if there was selection into treatment.
“This may not be plausible if early adopters had a different experience of the policy (e.g., a pilot phase) or if there was selection into treatment.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
InterpretationreasoningSensitivity analyses such as bounding can help quantify the robustness of substantive conclusions when causal assumptions are violated.
“Sensitivity analyses like bounding can be helpful to quantify the robustness of substantive conclusions when causal assumptions are violated.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningSensitivity analyses can help when researchers suspect violations of the no anticipation assumption.
“Sensitivity analyses can also be helpful when researchers suspect violations of the no anticipation assumption.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: No anticipation: treatment has no effect before implementation.
Classified as probably not a substantial claim.
InterpretationreasoningWhen treated units initiate treatment at different times, group-time treatment effect estimation methods perform well with heterogeneous treatment effects across time and cohorts.
“When treated units initiate treatment at different times, we recommend that researchers default to group-time treatment effect estimation methods that perform well with heterogeneous treatment effects across time and cohorts.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Interpretationnone givenResearchers can relax assumptions by assuming parallel trends only in subgroups or conditional on covariates.
“They can also relax assumptions, for example by assuming parallel trends only in subgroups of the data or conditional on covariates.”
Quote in the paperSubstantial claim- The authors state this as an assumption: Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenWhen treatment is assigned at an aggregate level, analyzing individual-level data is unlikely to substantially increase power.
“When treatment is assigned at an aggregate level, analyzing individual-level data is unlikely to substantially increase power.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Premisenone givenNormal-based clustered robust inference is one of the most popular methods for clustering standard errors.
“Normal-based clustered robust inference (e.g., cluster robust in Stata) is one of the most popular methods for clustering standard errors.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationWild cluster bootstrap invokes an assumption of a balanced proportion of treated units among clusters, which may not be plausible in many DiD applications.
“However, despite strong simulation performance, the wild cluster bootstrap technically invokes an assumption of a balanced proportion of treated units among clusters, which may not be plausible in many DiD applications where the treatment is assigned at the cluster level (see Canay et al. [117]).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [117] source
- The authors state this as an assumption: Wild cluster bootstrap assumes a balanced proportion of treated units among clusters.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenNormal-based clustered inference requires both many treated and many untreated clusters.
“Finally, normal-based clustered inference requires both many treated and many untreated clusters.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningThe Conley-Taber approach requires errors in treated units to have the same distribution as untreated units, which may be violated under treatment effect heterogeneity.
“However, it requires that errors in the treated units have the same distribution as those in the untreated units, which may be violated under treatment effect heterogeneity.”
Quote in the paperSubstantial claim- The authors state this as an assumption: The Conley-Taber approach requires that errors in treated units have the same distribution as errors in untreated units.
Probably not a substantial claim: may not pass S2 (checkable). May combine two claims.
InterpretationreasoningResearchers should cluster standard errors at the level of treatment assignment and be wary of normal-based cluster inference if there are insufficient treatment or comparison clusters, applying alternatives.
“Taken together, researchers should cluster standard errors at the level of treatment assignment and be wary of normal-based cluster inference if there are insufficient numbers of treatment or comparison clusters and apply alternatives.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenDiD is one of the most popular observational causal inference tools in health policy and medical research.
“DiD is one of the most popular observational causal inference tools in health policy and medical research.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable), S3 (load-bearing), S4 (based).
Interpretationnone givenWhen an intervention is introduced first in a few cities or states, DiD can support evaluation and learning from early adopters before scaling to additional locations.
“When an intervention is introduced first in a few cities or states, DiD can support evaluation and learning from early adopters before scaling to additional locations.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationcitationSimulations suggest wild cluster bootstrap methods can perform well with about five clusters, though estimates may be conservative when the proportion of treated units is small.
“Simulations suggest that these methods can perform well with about five clusters, although estimates may be conservative when the proportion of treated units is small (Table 4, row 2) [39, 114, 116].”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenIn DiD studies, treatment generally occurs at an aggregate level, but data may be collected at the same or a more granular level.
“In DiD studies, treatment generally occurs at an aggregate level (e.g., state), but data may be collected either at the same aggregated or a more granular level.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningWhen there are not many treated and untreated clusters, researchers should choose alternatives that require weaker assumptions.
“When this is not the case, researchers should opt for alternatives that require weaker assumptions.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe wild cluster bootstrap, or wild score bootstrap for generalized linear models, is a popular approach for small-cluster inference.
“One popular approach is the wild cluster bootstrap (or wild score bootstrap for generalized linear models) [41].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [41] source
The authors state this as an assumption.
Treatment and comparison groups would have had parallel average outcome trajectories absent the intervention.
“The key identifying assumption in DiD is the “parallel trends assumption,” which requires that on average, outcomes for treatment and comparison groups would have had parallel trajectories in the absence of the intervention.”
The authors state this as an assumption.
The treatment has no effect on treated units before the intervention begins.
“Second, the no-anticipation assumption states that the treatment has no effect on the treated units prior to the intervention.”
The authors state this as an assumption.
One unit's potential outcomes do not depend on other units' treatment status, implying no spillovers.
“Third, the Stable Unit Treatment Value Assumption (SUTVA) requires that the potential outcomes of one unit do not depend on the treatment status of any other units, which implies no spillover effects.”
The authors state this as an assumption.
Average untreated outcome changes are equal across adoption cohorts over time.
“For every adoption cohort Ei=e≠e′ that initiated treatment at time e and every pair of time periods t≠s [34]: E[Yi,t(0)−Yi,s(0)∣Ei=e]=E[Yi,t(0)−Yi,s(0)∣Ei=e′]”
The authors state this as an assumption.
Parallel trends holds within covariate-defined strata.
“This implies parallel trends within populations in covariate-defined strata (e.g., parallel trends within smokers and non-smokers): [17, 34]”
The authors state this as an assumption.
In the traditional setup, all treated units begin treatment at the same time period.
“Traditionally, DiD assumes we have N1 treated units and N0 comparison units, and treatment begins for all treated units at the same time period T*.”
The authors state this as an assumption.
The model has no separate intercept because it is absorbed by the fixed effects.
“We do not specify an intercept term, assuming this is absorbed in the fixed effect terms.”
The authors state this as an assumption.
Conditional parallel trends: for t1<T*, t2≥T*, and covariates Xi, the expected untreated outcome change is equal across treated and comparison groups conditional on Xi.
“For t1<T∗, t2≥T∗, and a vector of covariates Xi, E[Yi,t2(0)−Yi,t1(0)∣Di=1,Xi]=E[Yi,t2(0)−Yi,t1(0)∣Di=0,Xi]”
The authors state this as an assumption.
No anticipation: treatment has no effect before implementation.
“Sensitivity analyses can also be helpful when researchers suspect violations of the no anticipation assumption.”
The authors state this as an assumption.
Strong parallel trends (Assumption 4) holds.
“motivated by strong parallel trends (Assumption 4)”
The authors state this as an assumption.
Wild cluster bootstrap assumes a balanced proportion of treated units among clusters.
“the wild cluster bootstrap technically invokes an assumption of a balanced proportion of treated units among clusters”
The authors state this as an assumption.
The Conley-Taber approach requires that errors in treated units have the same distribution as errors in untreated units.
“it requires that errors in the treated units have the same distribution as those in the untreated units”
The authors state this as an assumption.
Conformal inference assumes that the proportion of treated units in each cluster varies little over time and imposes strong parallel trends over all pre- and post-treatment periods.
“it assumes that the proportion of treated units in each cluster to vary little over time and imposes a strong parallel trends assumption over all pre- and post-treatment periods [42].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
The TWFE equation labels the time effect with the wrong index
MinorThe model description says the second fixed effect varies by time period, but the displayed equation uses the unit index instead. That makes the notation internally inconsistent within the same paragraph.
“Researchers posit the model: (2) Yi,t=ηi+τi+δDi𝕝(t≥T∗)+ϵi,t where Yi,t is the outcome for unit i at time t, for i = 1, …, N (the total number of units) and t = 1, …, T (the total number of time periods).”
“ηi is the fixed-effect for each unit i, τt is the fixed-effect for each time period t, and ϵi,t is the idiosyncratic error for unit i at time t.”
The ATT formula does not calculate a difference-in-differences
MinorThe final parenthesized term subtracts the comparison group's pre-intervention outcome from the treated group's post-intervention outcome. It should instead subtract the comparison group's pre-intervention outcome from its post-intervention outcome, as the accompanying description states.
“ATT=E[Yi,t(1)−Yi,t(0)∣Di=1,t≥T∗]=E[Yi,t∣Di=1,t≥T∗]−E[Yi,t∣Di=1,t<T∗]−(E[Yi,t∣Di=1,t≥T∗]−E[Yi,t∣Di=0,t<T∗])”
“In this expression, the ATT is the difference in average treatment and comparison outcomes after versus before the intervention.”
The time fixed effect has the wrong index in Equation 2
MinorThe equation indexes τ by unit i, while the immediately following definition indexes it by time t. As printed, both fixed-effect terms in the equation are unit-indexed.
“(2) Yi,t=ηi+τi+δDi𝕝(t≥T∗)+ϵi,t”
“ηi is the fixed-effect for each unit i, τt is the fixed-effect for each time period t, and ϵi,t is the idiosyncratic error for unit i at time t.”
Cites
Difference-in-Differences with multiple time periods
Callaway, B., & Sant’Anna, P. H. C. (2021) · Journal of Econometrics · doi:10.1016/j.jeconom.2020.12.001 · Cited by 9,126 · see citing works
Difference-in-differences with variation in treatment timing
Goodman-Bacon, A. (2021) · Journal of Econometrics · doi:10.1016/j.jeconom.2021.03.014 · Cited by 8,046 · see citing works
Estimating dynamic treatment effects in event studies with heterogeneous treatment effects
Sun, L., & Abraham, S. (2021) · Journal of Econometrics · doi:10.1016/j.jeconom.2020.09.006 · Cited by 5,518 · see citing works
Matching as an econometric evaluation estimator: Evidence from evaluating a job training programme
Heckman, J. J., Ichimura, H., & Todd, P. E. (1997) · The Review of Economic Studies · doi:10.2307/2971733 · Cited by 5,486 · see citing works
Two-Way Fixed Effects Estimators with Heterogeneous Treatment Effects
de Chaisemartin, C., & D’Haultfœuille, X. (2020) · American Economic Review · doi:10.1257/aer.20181169 · Cited by 5,031 · see citing works
Fisher, R. A. (1936) · BMJ · doi:10.1136/bmj.1.3923.554-a · Cited by 4,980 · see citing works
Bootstrap-Based Improvements for Inference With Clustered Errors
Cameron, A. C., Gelbach, J. B., & Miller, D. L. (2008) · Review of Economics and Statistics · doi:10.1162/rest.90.3.414 · Cited by 4,417 · see citing works
How Much Should We Trust Staggered Difference-in-Differences Estimates?
Baker, A. C., Larcker, D. F., & Wang, C. C. Y. (2022) · Journal of Financial Economics · doi:10.1016/j.jfineco.2022.01.004 · Cited by 3,149 · see citing works
The Effect of Minimum Wages on Low-Wage Jobs*
Cengiz, D., Dube, A., Lindner, A., & Zipperer, B. (2019) · The Quarterly Journal of Economics · doi:10.1093/qje/qjz014 · Cited by 2,688 · see citing works
Semiparametric Difference-in-Differences Estimators
Abadie, A. (2005) · The Review of Economic Studies · doi:10.1111/0034-6527.00321 · Cited by 2,286 · see citing works
Revisiting Event-Study Designs: Robust and Efficient Estimation
Borusyak, K., Jaravel, X., & Spiess, J. (2024) · Review of Economic Studies · doi:10.1093/restud/rdae007 · Cited by 2,280 · see citing works
What's trending in difference-in-differences? A synthesis of the recent econometrics literature
Roth, J., Sant’Anna, P. H. C., Bilinski, A., & Poe, J. (2023) · Journal of Econometrics · doi:10.1016/j.jeconom.2023.03.008 · Cited by 2,027 · cited 5× · see citing works
“Third, the Stable Unit Treatment Value Assumption (SUTVA) requires that the potential outcomes of one unit do not depend on the treatment status of any other units, which implies no spillover effects.”
InfluentialSelf-citationA More Credible Approach to Parallel Trends
Rambachan, A., & Roth, J. (2023) · Review of Economic Studies · doi:10.1093/restud/rdad018 · Cited by 1,559 · see citing works
When Should You Adjust Standard Errors for Clustering?
Abadie, A., Athey, S., Imbens, G. W., & Wooldridge, J. M. (2022) · The Quarterly Journal of Economics · doi:10.1093/qje/qjac038 · Cited by 1,460 · see citing works
Inference with Difference-in-Differences and Other Panel Data
Donald, S. G., & Lang, K. (2007) · Review of Economics and Statistics · doi:10.1162/rest.89.2.221 · Cited by 1,324 · see citing works
Doubly robust difference-in-differences estimators
Sant’Anna, P. H. C., & Zhao, J. (2020) · Journal of Econometrics · doi:10.1016/j.jeconom.2020.06.003 · Cited by 1,047 · see citing works
Fast and wild: Bootstrap inference in Stata using boottest
Roodman, D., Nielsen, M. Ø., MacKinnon, J. G., & Webb, M. D. (2019) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x19830877 · Cited by 1,007 · see citing works
Did Unilateral Divorce Laws Raise Divorce Rates? A Reconciliation and New Results
Wolfers, J. (2006) · American Economic Review · doi:10.1257/aer.96.5.1802 · Cited by 950 · see citing works
The Estimation of Causal Effects by Difference-in-Difference Methods
Lechner, M. (2011) · Foundations and Trends® in Econometrics · doi:10.1561/0800000014 · Cited by 935 · see citing works
Pretest with Caution: Event-Study Estimates after Testing for Parallel Trends
Roth, J. (2022) · American Economic Review: Insights · doi:10.1257/aeri.20210236 · Cited by 769 · see citing works
Characterizing Selection Bias Using Experimental Data
Heckman, J., Ichimura, H., Smith, J., & Todd, P. (1998) · doi:10.3386/w6699 · Cited by 696 · see citing works
Inference with “Difference in Differences” with a Small Number of Policy Changes
Conley, T. G., & Taber, C. R. (2011) · Review of Economics and Statistics · doi:10.1162/rest_a_00049 · Cited by 633 · see citing works
Stuart, E. A., Huskamp, H. A., Duckworth, K. S., Simmons, J. B., Song, Z., Chernew, M. E., & Barry, C. L. (2014) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-014-0123-z · Cited by 535 · see citing works
Two-way fixed effects and differences-in-differences with heterogeneous treatment effects: a survey
de Chaisemartin, C., & D’Haultfœuille, X. (2023) · The Econometrics Journal · doi:10.1093/ectj/utac017 · Cited by 522 · see citing works
Two-Way Fixed Effects, the Two-Way Mundlak Regression, and Difference-in-Differences Estimators
Wooldridge, J. M. (2021) · SSRN / The Econometrics Journal · doi:10.2139/ssrn.3906345 · Cited by 517 · see citing works
Health and Access to Care during the First 2 Years of the ACA Medicaid Expansions
Miller, S., & Wherry, L. (2017) · New England Journal of Medicine · doi:10.1056/nejmsa1612890 · Cited by 479 · see citing works
Pre-Event Trends in the Panel Event-Study Design
Freyaldenhoven, S., Hansen, C., & Shapiro, J. M. (2019) · American Economic Review · doi:10.1257/aer.20180609 · Cited by 427 · see citing works
Raifman, J., Moscoe, E., Austin, S. B., & McConnell, M. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.4529 · Cited by 426 · see citing works
Kahn-Lang, A., & Lang, K. (2020) · Journal of Business & Economic Statistics · doi:10.1080/07350015.2018.1546591 · Cited by 367 · see citing works
Two-stage differences in differences
Gardner, J. (2022) · arXiv · doi:10.48550/arxiv.2207.05943 · Cited by 333 · cited 2× · see citing works
“The remaining adjustment methods included dynamic TWFE ( n = 2), two-stage DiD proposed by Gardner [47] ( n = 1), and the d’Chaisemartin and D’Haultfoeuille estimator [33] ( n = 1).”
Why We Should Not Be Indifferent to Specification Choices for Difference‐in‐Differences
Ryan, A. M., Burgess, J. F., & Dimick, J. B. (2015) · Health Services Research · doi:10.1111/1475-6773.12270 · Cited by 320 · see citing works
Self-citationThe wild bootstrap for few (treated) clusters
MacKinnon, J. G., & Webb, M. D. (2018) · The Econometrics Journal · doi:10.1111/ectj.12107 · Cited by 317 · see citing works
Two-Year Evaluation of Mandatory Bundled Payments for Joint Replacement
Barnett, M. L., Wilcock, A. D., McWilliams, J. M., Epstein, A. M., Maddox, K. E. J., Orav, E. J., Grabowski, D. C., & Mehrotra, A. (2019) · New England Journal of Medicine · doi:10.1056/nejmsa1809010 · Cited by 295 · see citing works
Matching and Regression to the Mean in Difference‐in‐Differences Analysis
Daw, J. R., & Hatfield, L. A. (2018) · Health Services Research · doi:10.1111/1475-6773.12993 · Cited by 270 · see citing works
Medicare Spending after 3 Years of the Medicare Shared Savings Program
McWilliams, J. M., Hatfield, L. A., Landon, B. E., Hamed, P., & Chernew, M. E. (2018) · New England Journal of Medicine · doi:10.1056/nejmsa1803388 · Cited by 269 · see citing works
Simple approaches to nonlinear difference-in-differences with panel data
Wooldridge, J. M. (2023) · The Econometrics Journal · doi:10.1093/ectj/utad016 · Cited by 260 · see citing works
Causal Inference About the Effects of Interventions From Observational Studies in Medical Journals
Dahabreh, I. J., & Bibbins-Domingo, K. (2024) · JAMA · doi:10.1001/jama.2024.7741 · Cited by 242 · see citing works
Antwi, Y. A., Moriya, A. S., & Simon, K. (2013) · American Economic Journal: Economic Policy · doi:10.1257/pol.5.4.1 · Cited by 223 · see citing works
Estimating causal effects: considering three alternatives to difference-in-differences estimation
O’Neill, S., Kreif, N., Grieve, R., Sutton, M., & Sekhon, J. S. (2016) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-016-0146-8 · Cited by 210 · see citing works
An Exact and Robust Conformal Inference Method for Counterfactual and Synthetic Controls
Chernozhukov, V., Wüthrich, K., & Zhu, Y. (2021) · Journal of the American Statistical Association · doi:10.1080/01621459.2021.1920957 · Cited by 176 · see citing works
The impact of the Philadelphia beverage tax on purchases and consumption by adults and children
Cawley, J., Frisvold, D., Hill, A., & Jones, D. J. (2019) · Journal of Health Economics · doi:10.1016/j.jhealeco.2019.102225 · Cited by 175 · see citing works
Venkataramani, A. S., Bair, E. F., O’Brien, R. L., & Tsai, A. C. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.5686 · Cited by 168 · see citing works
Changes in Hospital Adverse Events and Patient Outcomes Associated With Private Equity Acquisition
Kannan, S., Bruch, J. D., & Song, Z. (2023) · JAMA · doi:10.1001/jama.2023.23147 · Cited by 168 · see citing works
Evaluation of Medicare’s Bundled Payments Initiative for Medical Conditions
Maddox, K. E. J., Orav, E. J., Zheng, J., & Epstein, A. M. (2018) · New England Journal of Medicine · doi:10.1056/nejmsa1801569 · Cited by 162 · see citing works
Manski, C. F., & Pepper, J. V. (2018) · Review of Economics and Statistics · doi:10.1162/rest_a_00689 · Cited by 158 · see citing works
Confounding and regression adjustment in <scp>difference‐in‐differences</scp> studies
Zeldow, B., & Hatfield, L. A. (2021) · Health Services Research · doi:10.1111/1475-6773.13666 · Cited by 153 · see citing works
Association of Medicaid Expansion With Cardiovascular Mortality
Khatana, S. A. M., Bhatla, A., Nathan, A. S., Giri, J. S., Shen, C., Kazi, D. S., Yeh, R. W., & Groeneveld, P. W. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.1651 · Cited by 150 · see citing works
When Is Parallel Trends Sensitive to Functional Form?
Roth, J., & Sant'Anna, P. H. C. (2023) · Econometrica · doi:10.3982/ecta19402 · Cited by 142 · see citing works
Nothing to See Here? A Non‐Inferiority Approach to Parallel Trends
Bilinski, A., & Hatfield, L. A. (2026) · Statistics in Medicine · doi:10.1002/sim.70296 · Cited by 137 · see citing works
Self-citationTrends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021
Mafi, J. N., Craff, M., Vangala, S., Pu, T., Skinner, D., Tabatabai-Yazdi, C., Nelson, A., Reid, R., Agniel, D., Tseng, C.-H., et al. (2022) · JAMA · doi:10.1001/jama.2021.24294 · Cited by 120 · see citing works
Schell, T. L., Cefalu, M., Griffin, B. A., Smart, R., & Morral, A. R. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1921965117 · Cited by 118 · see citing works
The Wild Bootstrap with a “Small” Number of “Large” Clusters
Canay, I. A., Santos, A., & Shaikh, A. M. (2021) · The Review of Economics and Statistics · doi:10.1162/rest_a_00887 · Cited by 104 · see citing works
Raifman, J., Moscoe, E., Austin, S. B., Hatzenbuehler, M. L., & Galea, S. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0757 · Cited by 101 · see citing works
Reflection on modern methods: when worlds collide—prediction, machine learning and causal inference
Blakely, T., Lynch, J., Simons, K., Bentley, R., & Rose, S. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyz132 · Cited by 98 · see citing works
Double/debiased machine learning for difference-in-differences models
Chang, N.-C. (2020) · The Econometrics Journal · doi:10.1093/ectj/utaa001 · Cited by 93 · see citing works
Wing, C., Yozwiak, M., Hollingsworth, A., Freedman, S., & Simon, K. (2024) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-061022-050825 · Cited by 82 · see citing works
The anticipatory effects of Medicare Part D on drug utilization
Alpert, A. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.06.004 · Cited by 69 · see citing works
Gruber, S., Logan, R. W., Jarrín, I., Monge, S., & Hernán, M. A. (2015) · Statistics in Medicine · doi:10.1002/sim.6322 · Cited by 64 · see citing works
La Forgia, A., Bond, A. M., Braun, R. T., Yao, L. Z., Kjaer, K., Zhang, M., & Casalino, L. P. (2022) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2022.0004 · Cited by 63 · see citing works
A Bayesian Alternative to Synthetic Control for Comparative Case Studies
Pang, X., Liu, L., & Xu, Y. (2022) · Political Analysis · doi:10.1017/pan.2021.22 · Cited by 57 · cited 1× · see citing works
“…model is correctly specified: [29] 𝐴𝑇𝑇 DR = 𝔼 Other innovations in confounding adjustment methods include Bayesian approaches for trajectory modeling [96, 97], machine learning to estimate weights for IPW and doubly robust estimators [98–100], and IPW approaches driven by latent variables or…”
Alten, J., Cooper, D. S., Klugman, D., Raymond, T. T., Wooton, S., Garza, J., Clarke-Myers, K., Anderson, J., Pasquali, S. K., Absi, M., et al. (2022) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2022.2238 · Cited by 55 · see citing works
A Tutorial on Applying the Difference-in-Differences Method to Health Data
Rothbard, S., Etheridge, J. C., & Murray, E. J. (2023) · Current Epidemiology Reports · doi:10.1007/s40471-023-00327-x · Cited by 54 · see citing works
Rokicki, S., Cohen, J., Fink, G., Salomon, J. A., & Landrum, M. B. (2018) · Medical Care · doi:10.1097/mlr.0000000000000830 · Cited by 53 · see citing works
Difference-in-Difference in the Time of Cholera: a Gentle Introduction for Epidemiologists
Caniglia, E. C., & Murray, E. J. (2020) · Current Epidemiology Reports · doi:10.1007/s40471-020-00245-2 · Cited by 52 · see citing works
Bentley, R., Baker, E., Simons, K., Simpson, J. A., & Blakely, T. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy116 · Cited by 52 · see citing works
Impact Evaluation of Coronavirus Disease 2019 Policy: A Guide to Common Design Issues
Haber, N., Clarke‐Deelder, E., Salomon, J. A., Feller, A., & Stuart, E. A. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab185 · Cited by 51 · see citing works
Causal models for longitudinal and panel data: a survey
Arkhangelsky, D., & Imbens, G. (2024) · The Econometrics Journal · doi:10.1093/ectj/utae014 · Cited by 50 · see citing works
Causal Panel Analysis under Parallel Trends: Lessons from a Large Reanalysis Study
CHIU, A., LAN, X., LIU, Z., & XU, Y. (2026) · American Political Science Review · doi:10.1017/s0003055425000243 · Cited by 48 · see citing works
Understanding Marginal Structural Models for Time-Varying Exposures: Pitfalls and Tips
Shinozaki, T., & Suzuki, E. (2020) · Journal of Epidemiology · doi:10.2188/jea.je20200226 · Cited by 44 · see citing works
Sandoval-Olascoaga, S., Venkataramani, A. S., & Arcaya, M. C. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.29041 · Cited by 41 · see citing works
Policy evaluation during a pandemic
Callaway, B., & Li, T. (2023) · Journal of Econometrics · doi:10.1016/j.jeconom.2023.03.009 · Cited by 38 · cited 1× · see citing works
“: Second, the no-anticipation assumption states that the treatment has no effect on the treated units prior to the intervention.”
Haber, N. A., Clarke-Deelder, E., Feller, A., Smith, E. R., Salomon, J. A., MacCormack-Gelles, B., Stone, E. M., Bolster-Foucault, C., Daw, J. R., Hatfield, L. A., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-053820 · Cited by 36 · see citing works
Self-citationAustin, A. E., Shanahan, M. E., Frank, M., Naumann, R. B., McNaughton Reyes, H. L., Corbie, G., & Ammerman, A. S. (2023) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2022.5348 · Cited by 35 · see citing works
Physician EHR Time and Visit Volume Following Adoption of Team-Based Documentation Support
Apathy, N. C., Holmgren, A. J., & Cross, D. A. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.4123 · Cited by 34 · see citing works
Universal Difference-in-Differences for Causal Inference in Epidemiology
Tchetgen, E. J. T., Park, C., & Richardson, D. B. (2023) · Epidemiology · doi:10.1097/ede.0000000000001676 · Cited by 33 · see citing works
Ganguli, I., Souza, J., McWilliams, J. M., & Mehrotra, A. (2019) · Health Affairs · doi:10.1377/hlthaff.2019.00304 · Cited by 32 · see citing works
Self-citationTesting for Equivalence of Pre-Trends in Difference-in-Differences Estimation
Dette, H., & Schumann, M. (2024) · Journal of Business & Economic Statistics · doi:10.1080/07350015.2024.2308121 · Cited by 30 · cited 1× · see citing works
“Third, the Stable Unit Treatment Value Assumption (SUTVA) requires that the potential outcomes of one unit do not depend on the treatment status of any other units, which implies no spillover effects.”
British Columbia’s safer opioid supply policy and opioid outcomes.
Nguyen, H. V., Mital, S., Bugden, S., & McGinty, E. E. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.7570 · Cited by 29 · see citing works
Schoenbrunner, A. R., Beckmeyer, A., Kunnath, N. J., Ibrahim, A. M., Pawlik, T. M., Venkataramani, A. S., Kuzon, W. M., & Díaz, A. (2023) · JAMA · doi:10.1001/jama.2023.0878 · Cited by 29 · see citing works
Well‐Balanced or too Matchy–Matchy? The Controversy over Matching in Difference‐in‐Differences
Ryan, A. M. (2018) · Health Services Research · doi:10.1111/1475-6773.13015 · Cited by 28 · see citing works
Self-citationBirds of a feather flock together: Comparing controlled pre–post designs
Fry, C. E., & Hatfield, L. A. (2021) · Health Services Research · doi:10.1111/1475-6773.13697 · Cited by 28 · see citing works
Insulin Fills by Medicare Enrollees and Out-of-Pocket Caps Under the Inflation Reduction Act
Myerson, R., Qato, D. M., Goldman, D. P., & Romley, J. A. (2023) · JAMA · doi:10.1001/jama.2023.12951 · Cited by 27 · see citing works
The Comprehensive Primary Care Plus Model and Health Care Spending, Service Use, and Quality
Singh, P., Fu, N., Dale, S., Orzol, S., Laird, J., Markovitz, A., Shin, E., O’Malley, A. S., McCall, N., & Day, T. J. (2024) · JAMA · doi:10.1001/jama.2023.24712 · Cited by 27 · see citing works
Association Between Restricted Abortion Access and Child Entries Into the Foster Care System
Adkins, S., Talmor, N., White, M. H., Dutton, C., & O’Donoghue, A. L. (2024) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2023.4738 · Cited by 25 · see citing works
Shashikumar, S. A., Gulseren, B., Berlin, N. L., Hollingsworth, J. M., Joynt Maddox, K. E., & Ryan, A. M. (2022) · JAMA · doi:10.1001/jama.2022.18529 · Cited by 21 · see citing works
Self-citationInference with a single treated cluster
Hagemann, A. (2020) · arXiv · doi:10.48550/arxiv.2010.04076 · Cited by 18 · see citing works
Steenland, M. W., Pace, L. E., & Cohen, J. L. (2022) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2021.5688 · Cited by 17 · see citing works
Hospital Assets Before and After Private Equity Acquisition
(2024) · doi:10.1001/jama.2024.13555 · Cited by 17 · see citing works
Difference in Differences with Time-Varying Covariates
(2022) · doi:10.48550/arxiv.2202.02903 · Cited by 17 · see citing works
Ganguli, I., Lim, C., Daley, N., Cutler, D., Rosenthal, M., & Mehrotra, A. (2025) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.8354 · Cited by 16 · see citing works
Self-citationDuan, K. I., Obara, E., Wong, E. S., Liao, J. M., Sabbatini, A. K., Donovan, L. M., Spece, L. J., Feemster, L. C., & Au, D. H. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.5738 · Cited by 15 · see citing works
A Negative Correlation Strategy for Bracketing in Difference-in-Differences
Ye, T., Keele, L. J., Hasegawa, R. B., & Small, D. S. (2023) · Journal of the American Statistical Association · doi:10.1080/01621459.2023.2252576 · Cited by 15 · see citing works
Changes in Health Care Workers’ Economic Outcomes Following Medicaid Expansion
Matta, S., Chatterjee, P., & Venkataramani, A. S. (2024) · JAMA · doi:10.1001/jama.2023.27014 · Cited by 14 · see citing works
Pharmacy Closures and Anticonvulsant Medication Prescription Fills
Anderson, K. E., Sahu, M., DiStefano, M. J., Asche, C. V., & Mattingly, T. J. (2024) · JAMA · doi:10.1001/jama.2024.19993 · Cited by 13 · see citing works
Liang, Y., Rees, D. I., Sabia, J. J., & Smiley, C. (2023) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2023.0018 · Cited by 12 · see citing works
Deb, P., Norton, E., Wooldridge, J., & Zabel, J. (2024) · doi:10.3386/w33026 · Cited by 10 · see citing works
Alternative Payment Models and Performance in Federally Qualified Health Centers
Markowski, J., Wallace, J., Schlesinger, M., & Ndumele, C. D. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.2754 · Cited by 10 · see citing works
Patterns of Effects and Sensitivity Analysis for Differences-in-Differences
Keele, L. J., Small, D. S., Hsu, J. Y., & Fogarty, C. B. (2019) · arXiv · doi:10.48550/arxiv.1901.01869 · Cited by 10 · see citing works
Shingles Vaccination in Medicare Part D After Inflation Reduction Act Elimination of Cost Sharing
Qato, D. M., Romley, J. A., Myerson, R., Goldman, D., & Fendrick, A. M. (2024) · JAMA · doi:10.1001/jama.2024.7348 · Cited by 9 · see citing works
Doubly robust estimation of policy-relevant causal effects under interference
Hettinger, G., Roberto, C., Lee, Y., & Mitra, N. (2025) · Journal of the Royal Statistical Society Series C: Applied Statistics · doi:10.1093/jrsssc/qlae066 · Cited by 8 · see citing works
Self-citationMedicaid Accountable Care Organizations and Disparities in Pediatric Asthma Care
Geissler, K. H., Shieh, M.-S., Ash, A. S., Lindenauer, P. K., Krishnan, J. A., & Goff, S. L. (2024) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2024.3935 · Cited by 7 · see citing works
Clinical Outcomes After Admission of Patients With COVID-19 to Skilled Nursing Facilities
McGarry, B. E., Gandhi, A. D., Chughtai, M.-A., Yin, J., & Barnett, M. L. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.1079 · Cited by 7 · see citing works
Feng, S., & Bilinski, A. (2024) · medRxiv · doi:10.1101/2024.04.08.24305335 · Cited by 7 · see citing works
Self-citationChanges in Emergency Contraceptive Fills After Massachusetts’ Statewide Standing Order
Qato, D. M., Guadamuz, J. S., & Myerson, R. (2024) · JAMA · doi:10.1001/jama.2024.11715 · Cited by 5 · see citing works
Aggregating Average Treatment Effects on the Treated in Difference-in-Differences Models
Deb, P., Norton, E., Wooldridge, J., & Zabel, J. (2025) · doi:10.3386/w34331 · Cited by 2 · see citing works
Causal Duration Analysis With Diff‐in‐Diff
Deaner, B., & Ku, H. (2024) · arXiv · doi:10.48550/arxiv.2405.05220 · Cited by 1 · see citing works
Flagged first, then by citations
2 of the 113 references couldn’t be matched to a known paper.
Research works printed but not linked: 5
- World Health Organization, 2024, Evaluating the Impact of Interventions Addressing Health Behaviour: Considerations and Tools for Policy‐Makers
- Medicine NLo “Difference‐in‐Differences”—PubMed Search Results2025 https://pubmed.ncbi.nlm.nih.gov/?term=%22difference‐in‐differences%22&filter=years.2008‐2025.
- Hettinger G., 2023, Estimation of Policy‐Relevant Causal Effects in the Presence of Interference With an Application to the Philadelphia Beverage Tax, arXiv, 2
- Rambachan A., 2020, Design‐Based Uncertainty for Quasi‐Experiments, arXiv, 7
- Alvarez L., 2025, Inference With Few Treated Units, arXiv, 2
Cited by
Sorted by citations
Cost-Related Medication Nonadherence After the Inflation Reduction Act
Marinacci, L., Mein, S. A., Rome, B. N., & Wadhera, R. K. (2026) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2026.0012 · Cited by 9 · see citing works
Guide to recent advances in difference-in-differences methodology for population health studies
Sutton, M., Francetic, I. N. ;., O’Neill, S., Hugh-Jones, S., & Munford, L. A. (2026) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2025-225449 · Cited by 2 · see citing works
Conducting evaluations using routine health information system data: A researcher’s guide
Grépin, K. A., Hotchkiss, D. R., Feng, S., & Law, M. R. (2026) · SSM - Health Systems · doi:10.1016/j.ssmhs.2026.100214 · Cited by 1 · see citing works
Self-citationMedicaid Expansion and Mortality Among Patients With Colorectal Cancer
Akinyemi, O. A., Oyebanji, O., Oluborode, B., et al. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.34827 · Cited by 1 · see citing works
Lindner, S., & McConnell, K. J. (2026) · Health Services and Outcomes Research Methodology · doi:10.1007/s10742-026-00396-7
Estimating Intervention Effects With Difference-in-Differences
Bilinski, A., Feng, S., & Hatfield, L. A. (2026) · JAMA · doi:10.1001/jama.2026.12551 · Cited by 2 · see citing works
Self-citationAn, C., & Zhou, P. (2026) · ENGINEERING Management · doi:10.1007/s42524-026-6050-1
“These features limit the applicability of guides from other fields, e.g., agricultural economics (Henningsen et al., 2025), medical and health economics (Feng et al., 2025; Wang et al., 2024; Wing et al., 2024), and strategic management research (Frake et al., 2025).”
Li, Z., Pan, H., Liu, J., Zhang, T., Gao, R., Xia, G., Zeng, Z., Li, C., Huang, M., Luo, T., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10782783/v1
Adaranijo, E. (2025) · Hospital Practice · doi:10.1080/21548331.2025.2593812
“…test for parallel trends assumption using pre-intervention data to compare outcome trajectories, applying graphical or formal statistical tests [13]; incorporate staggered adoption to leverage multi-period DiD designs if hospitals implement IPC at different times [13]; enhance comparability by…”
InfluentialMedication and Acute Care Use in Young Adults With Opioid Use Subject to Medicaid Prescription Caps
Santostefano, C. M., Hughto, J. M. W., Hughes, L. D., Shireman, T. I., Andrews, C. M., Rosales, R., Donohue, J. M., Peterson, L., & Dow, P. M. (2026) · JAMA Health Forum · doi:10.1001/jamahealthforum.2026.1187
- Authors
- Feng, S., Ganguli, I., Lee, Y., Poe, J., Ryan, A., & Bilinski, A.
- Affiliations
- Brown University (US)
- Brigham and Women's Hospital (US)
- Hessian LLC Cabot Arkansas USA
- Corresponding author
- Bilinski, Alyssa
- Venue
- Statistics in Medicine
- Publisher
- Wiley
- Published
- 2025-10
- Volume
- 44
- Issue
- 23-24
- Pages
- e70247-e70247
- ISSN
- 0277-6715 (ISSN-L)
- 1097-0258
- PMC
- PMC13358929
- OpenAlex
- W4414905159
- Semantic Scholar
- 12f880923dd16bd2ac500197420aad184c11052e
- Cited by
- 16
- References
- 113
- Citations by year
- 2026: 14 · 2025: 2
- FWCI
- 16.65
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Statistics in Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- Centers for Disease Control and Prevention (NU38OT000297‐02)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK136515)
- National Institute on Aging (K23AG068240, 2P01AG027296‐16)
- National Institute of General Medical Sciences (1R35GM155224)
- Topics
- Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Healthcare Policy and Management
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Keywords
- difference-in-differences, parallel trends assumption, clustered standard errors, covariate adjustment, causal inference, health policy evaluation, treatment effect estimation, robust inference
- MeSH terms
- Health Policy, Humans, Models, Statistical, Causality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read under definition version 3 (extract-v3) on 2026-09-28.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-09-28.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review